RHEP

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 9

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 105,900

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

SEC source: 0001493152-26-027733 · ownership.xml · nonDerivative · entry 3

Morrison Brent · CIK 0001623063 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Indirect · By IRA

Disclosed balance after: 22,272

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 8

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 106,000

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

SEC source: 0001493152-26-027733 · ownership.xml · nonDerivative · entry 2

Morrison Brent · CIK 0001623063 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Indirect · By IRA

Disclosed balance after: 17,272

F1 · price: This transaction was executed in multiple trades at prices ranging from $1.15 to $1.20. The price reported in Column 4 is a weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were affected

SEC source: 0001493152-26-027733 · ownership.xml · nonDerivative · entry 4

Morrison Brent · CIK 0001623063 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Indirect · By IRA

Disclosed balance after: 17,000

SEC source: 0001493152-26-025104 · ownership.xml · nonDerivative · entry 3

Morrison Brent · CIK 0001623063 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Indirect · By IRA

Disclosed balance after: 11,300

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.98 to $2.01. The price reported in Column 4 is a weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

SEC source: 0001493152-26-025104 · ownership.xml · nonDerivative · entry 2

Morrison Brent · CIK 0001623063 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Indirect · By IRA

Disclosed balance after: 7,272

F1 · price: This transaction was executed in multiple trades at prices ranging from $1.22 to $1.34. The price reported in Column 4 is a weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

SEC source: 0001493152-26-021594 · ownership.xml · derivative · entry 2

Davis Marlie · CIK 0002133520 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2036-05-05

F3 · security: Employee stock option grant pursuant to the Regional Health Properties, Inc.'s Amended and Restated 2023 Omnibus Incentive Compensation Plan.

F4 · derivative.exercise_price: Based on the average of the high/low of Regional Health Properties, Inc. common stock on the OTC market on May 5, 2026.

F5 · derivative.exercise_date: The stock options will vest over a three-year period on the following schedule: (i) 11,667 shares on May 5, 2027, (ii) 11,667 shares on May 5, 2028, and (iii) 11,666 shares on May 5, 2029.

SEC source: 0001493152-26-021594 · ownership.xml · nonDerivative · entry 1

Davis Marlie · CIK 0002133520 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,000

F1 · shares: Restricted stock unit grant pursuant to the Regional Health Properties, Inc.'s Amended and Restated 2023 Omnibus Incentive Compensation Plan.

F2 · shares: The restricted stock unit will vest over a three-year period on the following schedule: (i) 11,667 shares on May 5, 2027, (ii) 11,667 shares on May 5, 2028, and (iii) 11,666 shares on May 5, 2029.

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 7

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 111,000

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 6

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 109,991

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 5

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 108,991

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 3

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 220,737

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · derivative · entry 11

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,263

Underlying: Common Stock · 377 shares

Expires not disclosed

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · derivative.exercise_price: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

F3 · derivative.exercise_date: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

F3 · derivative.expiration_date: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · derivative · entry 10

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,263

Underlying: Common Stock · 226 shares

Expires not disclosed

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F3 · derivative.exercise_price: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

F3 · derivative.exercise_date: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

F3 · derivative.expiration_date: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 2

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 218,737

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 4

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By The Radoff Family Foundation

Disclosed balance after: 108,491

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.

SEC source: 0000921895-26-001950 · form409076039_08042026.xml · nonDerivative · entry 1

Radoff Bradley Louis · CIK 0001380585 · 10% owner

Radoff Family Foundation · CIK 0001496916 · See Footnote 1

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 215,226

F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

SEC source: 0001493152-26-005039 · ownership.xml · derivative · entry 3

Morrison Brent · CIK 0001623063 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2036-01-16

F3 · derivative.exercise_price: Based on the average of the high/low of Regional Health Properties, Inc. common stock on the OTC market on January 16, 2026.

F4 · derivative.underlying_shares: The stock options will vest over a two-year period on the following schedule: (1) 50,000 shares on January 16, 2027; and (2) 50,000 shares of January 16, 2028.

SEC source: 0001493152-26-005039 · ownership.xml · nonDerivative · entry 1

Morrison Brent · CIK 0001623063 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 309,499

F1 · shares: Restricted stock granted pursuant to the Regional Health Properties, Inc.'s Amended and Restated 2023 Omnibus Incentive Compensation Plan.

F2 · shares: The shares of restricted stock will vest over a two-year period on the following schedule: (1) 50,000 shares on January 16, 2027; and (2) 50,000 shares of January 16, 2028.

SEC source: 0001493152-26-005698 · ownership.xml · derivative · entry 1

MARTIN STEVEN L · CIK 0001331865 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,000

Underlying: Common Stock · 3,000 shares

Expires 2036-01-16

F1 · security: Non-qualified stock options granted pursuant to the Regional Health Properties, Inc.'s Amended and Restated 2023 Omnibus Incentive Compensation Plan.

F2 · derivative.exercise_price: Based on the average of the high/low of Regional Health Properties, Inc. common stock on the OTC market on January 16, 2026.

F3 · derivative.exercise_date: The non-qualified stock options vest immediately.

SEC source: 0001493152-26-005696 · ownership.xml · derivative · entry 1

BAILEYS STEVEN J · CIK 0001247619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,000

Underlying: Common Stock · 3,000 shares

Expires 2036-01-16

F1 · security: Non-qualified stock options granted pursuant to the Regional Health Properties, Inc.'s Amended and Restated 2023 Omnibus Incentive Compensation Plan.

F2 · derivative.exercise_price: Based on the average of the high/low of Regional Health Properties, Inc. common stock on the OTC market on January 16, 2026.

F3 · derivative.exercise_date: The non-qualified stock options vest immediately.

SEC source: 0001493152-26-005692 · ownership.xml · derivative · entry 1

BURLESON GENE E · CIK 0001137623 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,000

Underlying: Common Stock · 3,000 shares

Expires 2036-01-16

F1 · security: Non-qualified stock options granted pursuant to the Regional Health Properties, Inc.'s Amended and Restated 2023 Omnibus Incentive Compensation Plan.

F2 · derivative.exercise_price: Based on the average of the high/low of Regional Health Properties, Inc. common stock on the OTC market on January 16, 2026.

F3 · derivative.exercise_date: The non-qualified stock options vest immediately.

SEC source: 0001493152-26-005694 · ownership.xml · derivative · entry 1

Taylor Kenneth Wayne · CIK 0001731952 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,000

Underlying: Common Stock · 3,000 shares

Expires 2036-01-16

F1 · security: Non-qualified stock options granted pursuant to the Regional Health Properties, Inc.'s Amended and Restated 2023 Omnibus Incentive Compensation Plan.

F2 · derivative.exercise_price: Based on the average of the high/low of Regional Health Properties, Inc. common stock on the OTC market on January 16, 2026.

F3 · derivative.exercise_date: The non-qualified stock options vest immediately.

SEC source: 0001493152-26-005690 · ownership.xml · derivative · entry 1

KELLMAN F SCOTT · CIK 0001098297 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,000

Underlying: Common Stock · 3,000 shares

Expires 2036-01-16

F1 · security: Non-qualified stock options granted pursuant to the Regional Health Properties, Inc.'s Amended and Restated 2023 Omnibus Incentive Compensation Plan.

F2 · derivative.exercise_price: Based on the average of the high/low of Regional Health Properties, Inc. common stock on the OTC market on January 16, 2026.

F3 · derivative.exercise_date: The non-qualified stock options vest immediately.

SEC source: 0001493152-26-005688 · ownership.xml · derivative · entry 1

WINKLE C CHRISTIAN · CIK 0001202992 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,000

Underlying: Common Stock · 3,000 shares

Expires 2036-01-16

F1 · security: Non-qualified stock options granted pursuant to the Regional Health Properties, Inc.'s Amended and Restated 2023 Omnibus Incentive Compensation Plan.

F2 · derivative.exercise_price: Based on the average of the high/low of Regional Health Properties, Inc. common stock on the OTC market on January 16, 2026.

F3 · derivative.exercise_date: The non-qualified stock options vest immediately.

SEC source: 0001493152-25-027286 · ownership.xml · nonDerivative · entry 2

Morrison Brent · CIK 0001623063 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 209,499

SEC source: 0001493152-25-027286 · ownership.xml · nonDerivative · entry 1

Morrison Brent · CIK 0001623063 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 207,549

SEC source: 0001493152-25-026796 · ownership.xml · nonDerivative · entry 1

Morrison Brent · CIK 0001623063 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 203,450

SEC source: 0001641172-25-026402 · ownership.xml · nonDerivative · entry 1

BURLESON GENE E · CIK 0001137623 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · The Burleson Family Foundation

Disclosed balance after: 5,000

SEC source: 0001641172-25-025228 · ownership.xml · nonDerivative · entry 4

O'sullivan Paul Jason · CIK 0001971851 · Senior Vice President

10b5-1 filing: No plan indicated

Ownership: Indirect · By IRA

Disclosed balance after: 33,500

SEC source: 0001641172-25-025228 · ownership.xml · nonDerivative · entry 3

O'sullivan Paul Jason · CIK 0001971851 · Senior Vice President

10b5-1 filing: No plan indicated

Ownership: Indirect · By IRA

Disclosed balance after: 29,700

F2 · price: This transaction was executed in multiple trades at prices ranging from $1.83 and $2.00. The reported price reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

SEC source: 0001641172-25-025228 · ownership.xml · nonDerivative · entry 2

O'sullivan Paul Jason · CIK 0001971851 · Senior Vice President

10b5-1 filing: No plan indicated

Ownership: Indirect · By IRA

Disclosed balance after: 24,100

F1 · price: This transaction was executed in multiple trades at prices ranging from $1.67 and $1.97. The reported price reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

SEC source: 0001641172-25-024707 · ownership.xml · nonDerivative · entry 10

BAILEYS STEVEN J · CIK 0001247619 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 320

F1 · price: At the effective time of the merger (the "Effective Time") between SunLink Health Systems, Inc. ("SunLink") and Regional Health Properties, Inc. ("Regional"), each five shares of common stock, no par value per share, of SunLink held by the Reporting Person prior to the Effective Time were converted into the right to receive (i) 1.1330 shares of common stock, no par value per share, of Regional, and (ii) one share of Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, no par value per share, of Regional.

SEC source: 0001641172-25-024707 · ownership.xml · nonDerivative · entry 9

BAILEYS STEVEN J · CIK 0001247619 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By IRA

Disclosed balance after: 36,000

F1 · price: At the effective time of the merger (the "Effective Time") between SunLink Health Systems, Inc. ("SunLink") and Regional Health Properties, Inc. ("Regional"), each five shares of common stock, no par value per share, of SunLink held by the Reporting Person prior to the Effective Time were converted into the right to receive (i) 1.1330 shares of common stock, no par value per share, of Regional, and (ii) one share of Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, no par value per share, of Regional.

SEC source: 0001641172-25-024707 · ownership.xml · nonDerivative · entry 8

BAILEYS STEVEN J · CIK 0001247619 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · As Trustee, Baileys Grandchildren's Trust FBO Alison Brooke Baileys

Disclosed balance after: 10,000

F1 · price: At the effective time of the merger (the "Effective Time") between SunLink Health Systems, Inc. ("SunLink") and Regional Health Properties, Inc. ("Regional"), each five shares of common stock, no par value per share, of SunLink held by the Reporting Person prior to the Effective Time were converted into the right to receive (i) 1.1330 shares of common stock, no par value per share, of Regional, and (ii) one share of Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, no par value per share, of Regional.

SEC source: 0001641172-25-024707 · ownership.xml · nonDerivative · entry 7

BAILEYS STEVEN J · CIK 0001247619 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · As Trustee, Baileys Grandchildren's Trust FBO Jeremy Baileys

Disclosed balance after: 10,000

F1 · price: At the effective time of the merger (the "Effective Time") between SunLink Health Systems, Inc. ("SunLink") and Regional Health Properties, Inc. ("Regional"), each five shares of common stock, no par value per share, of SunLink held by the Reporting Person prior to the Effective Time were converted into the right to receive (i) 1.1330 shares of common stock, no par value per share, of Regional, and (ii) one share of Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, no par value per share, of Regional.

SEC source: 0001641172-25-024707 · ownership.xml · nonDerivative · entry 6

BAILEYS STEVEN J · CIK 0001247619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,248

F1 · price: At the effective time of the merger (the "Effective Time") between SunLink Health Systems, Inc. ("SunLink") and Regional Health Properties, Inc. ("Regional"), each five shares of common stock, no par value per share, of SunLink held by the Reporting Person prior to the Effective Time were converted into the right to receive (i) 1.1330 shares of common stock, no par value per share, of Regional, and (ii) one share of Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, no par value per share, of Regional.

SEC source: 0001641172-25-024707 · ownership.xml · nonDerivative · entry 5

BAILEYS STEVEN J · CIK 0001247619 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 362

F1 · price: At the effective time of the merger (the "Effective Time") between SunLink Health Systems, Inc. ("SunLink") and Regional Health Properties, Inc. ("Regional"), each five shares of common stock, no par value per share, of SunLink held by the Reporting Person prior to the Effective Time were converted into the right to receive (i) 1.1330 shares of common stock, no par value per share, of Regional, and (ii) one share of Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, no par value per share, of Regional.

SEC source: 0001641172-25-024707 · ownership.xml · nonDerivative · entry 4

BAILEYS STEVEN J · CIK 0001247619 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By IRA

Disclosed balance after: 40,788

F1 · price: At the effective time of the merger (the "Effective Time") between SunLink Health Systems, Inc. ("SunLink") and Regional Health Properties, Inc. ("Regional"), each five shares of common stock, no par value per share, of SunLink held by the Reporting Person prior to the Effective Time were converted into the right to receive (i) 1.1330 shares of common stock, no par value per share, of Regional, and (ii) one share of Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, no par value per share, of Regional.

SEC source: 0001641172-25-024707 · ownership.xml · nonDerivative · entry 3

BAILEYS STEVEN J · CIK 0001247619 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · As Trustee, Baileys Grandchildren's Trust FBO Alison Brooke Baileys

Disclosed balance after: 11,330

F1 · price: At the effective time of the merger (the "Effective Time") between SunLink Health Systems, Inc. ("SunLink") and Regional Health Properties, Inc. ("Regional"), each five shares of common stock, no par value per share, of SunLink held by the Reporting Person prior to the Effective Time were converted into the right to receive (i) 1.1330 shares of common stock, no par value per share, of Regional, and (ii) one share of Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, no par value per share, of Regional.

SEC source: 0001641172-25-024707 · ownership.xml · nonDerivative · entry 2

BAILEYS STEVEN J · CIK 0001247619 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · As Trustee, Baileys Grandchildren's Trust FBO Jeremy Baileys

Disclosed balance after: 11,330

F1 · price: At the effective time of the merger (the "Effective Time") between SunLink Health Systems, Inc. ("SunLink") and Regional Health Properties, Inc. ("Regional"), each five shares of common stock, no par value per share, of SunLink held by the Reporting Person prior to the Effective Time were converted into the right to receive (i) 1.1330 shares of common stock, no par value per share, of Regional, and (ii) one share of Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, no par value per share, of Regional.

SEC source: 0001641172-25-024707 · ownership.xml · nonDerivative · entry 1

BAILEYS STEVEN J · CIK 0001247619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,911

F1 · price: At the effective time of the merger (the "Effective Time") between SunLink Health Systems, Inc. ("SunLink") and Regional Health Properties, Inc. ("Regional"), each five shares of common stock, no par value per share, of SunLink held by the Reporting Person prior to the Effective Time were converted into the right to receive (i) 1.1330 shares of common stock, no par value per share, of Regional, and (ii) one share of Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, no par value per share, of Regional.

SEC source: 0001641172-25-024709 · ownership.xml · nonDerivative · entry 5

THORNTON ROBERT M JR · CIK 0001137608 · EVP - Corporate Strategy

10b5-1 filing: No plan indicated

Ownership: Indirect · By IRA

Disclosed balance after: 1,000

F2 · price: At the effective time of the merger (the "Effective Time") between SunLink Health Systems, Inc. ("SunLink") and Regional, each five shares of common stock, no par value per share, of SunLink held by the Reporting Person prior to the Effective Time were converted into the right to receive (i) 1.1330 shares of common stock, no par value per share, of Regional, and (ii) one share of Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, no par value per share, of Regional.

SEC source: 0001641172-25-024709 · ownership.xml · nonDerivative · entry 4

THORNTON ROBERT M JR · CIK 0001137608 · EVP - Corporate Strategy

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 110,912

F2 · price: At the effective time of the merger (the "Effective Time") between SunLink Health Systems, Inc. ("SunLink") and Regional, each five shares of common stock, no par value per share, of SunLink held by the Reporting Person prior to the Effective Time were converted into the right to receive (i) 1.1330 shares of common stock, no par value per share, of Regional, and (ii) one share of Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, no par value per share, of Regional.

F3 · ownership.nature: Owned by CareVest Capital, L.L.C. ("CareVest"). Mr. Thornton owns 100% of the outstanding voting shares of CareVest and is reporting CareVest's total direct holdings of Regional shares.

SEC source: 0001641172-25-024709 · ownership.xml · nonDerivative · entry 3

THORNTON ROBERT M JR · CIK 0001137608 · EVP - Corporate Strategy

10b5-1 filing: No plan indicated

Ownership: Indirect · By IRA

Disclosed balance after: 1,133

F2 · price: At the effective time of the merger (the "Effective Time") between SunLink Health Systems, Inc. ("SunLink") and Regional, each five shares of common stock, no par value per share, of SunLink held by the Reporting Person prior to the Effective Time were converted into the right to receive (i) 1.1330 shares of common stock, no par value per share, of Regional, and (ii) one share of Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, no par value per share, of Regional.

SEC source: 0001641172-25-024709 · ownership.xml · nonDerivative · entry 2

THORNTON ROBERT M JR · CIK 0001137608 · EVP - Corporate Strategy

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 125,663

F2 · price: At the effective time of the merger (the "Effective Time") between SunLink Health Systems, Inc. ("SunLink") and Regional, each five shares of common stock, no par value per share, of SunLink held by the Reporting Person prior to the Effective Time were converted into the right to receive (i) 1.1330 shares of common stock, no par value per share, of Regional, and (ii) one share of Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, no par value per share, of Regional.

F3 · ownership.nature: Owned by CareVest Capital, L.L.C. ("CareVest"). Mr. Thornton owns 100% of the outstanding voting shares of CareVest and is reporting CareVest's total direct holdings of Regional shares.

SEC source: 0001641172-25-024709 · ownership.xml · nonDerivative · entry 1

THORNTON ROBERT M JR · CIK 0001137608 · EVP - Corporate Strategy

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

F1 · kind: Grant of restricted stock that was awarded to the Reporting Person as an inducement to his employment with Regional Health Properties, Inc. ("Regional"). The restricted stock will vest in three substantially equal installments on August 14, 2025, August 14, 2026 and August 14, 2027.

SEC source: 0001641172-25-024708 · ownership.xml · nonDerivative · entry 2

STOCKSLAGER MARK J · CIK 0001247637 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,610

F1 · price: At the effective time of the merger (the "Effective Time") between SunLink Health Systems, Inc. ("SunLink") and Regional Health Properties, Inc. ("Regional"), each five shares of common stock, no par value per share, of SunLink held by the Reporting Person prior to the Effective Time were converted into the right to receive (i) 1.1330 shares of common stock, no par value per share, of Regional, and (ii) one share of Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, no par value per share, of Regional.

SEC source: 0001641172-25-024708 · ownership.xml · nonDerivative · entry 1

STOCKSLAGER MARK J · CIK 0001247637 · CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,484

F1 · price: At the effective time of the merger (the "Effective Time") between SunLink Health Systems, Inc. ("SunLink") and Regional Health Properties, Inc. ("Regional"), each five shares of common stock, no par value per share, of SunLink held by the Reporting Person prior to the Effective Time were converted into the right to receive (i) 1.1330 shares of common stock, no par value per share, of Regional, and (ii) one share of Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, no par value per share, of Regional.